[Post-transplantation lymphoproliferative disorder accompanies acquired hemophilia after haploid hematopoietic stem cell transplantation in a pediatric AML patient: a case report and literature review].
作者信息
Jiao X L, Wang Y Q, Ai H, Wang Q, Zhou H, Fu Y W, Wei X D, Song Y P
机构信息
Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.
出版信息
Zhonghua Xue Ye Xue Za Zhi. 2019 Aug 14;40(8):691-693. doi: 10.3760/cma.j.issn.0253-2727.2019.08.015.
Abstract
摘要
相似文献
1
[Post-transplantation lymphoproliferative disorder accompanies acquired hemophilia after haploid hematopoietic stem cell transplantation in a pediatric AML patient: a case report and literature review].[儿童急性髓系白血病患者单倍体造血干细胞移植后移植后淋巴细胞增殖性疾病伴获得性血友病：一例报告及文献复习]
Zhonghua Xue Ye Xue Za Zhi. 2019 Aug 14;40(8):691-693. doi: 10.3760/cma.j.issn.0253-2727.2019.08.015.
2
Epstein-Barr virus-positive lymphoproliferative disorder manifesting as pulmonary disease in a patient with acute myeloid leukemia: a case report.EB 病毒阳性淋巴组织增生性疾病在急性髓系白血病患者中表现为肺部疾病：病例报告。
J Med Case Rep. 2021 Mar 28;15(1):170. doi: 10.1186/s13256-021-02744-2.
3
Secondary chronic myeloid leukemia following acute myeloid leukemia treated with autologous hematopoietic stem cell transplantation: a case report.自体造血干细胞移植治疗急性髓系白血病后继发慢性髓系白血病 2 例报告
Curr Med Res Opin. 2020 Nov;36(11):1807-1812. doi: 10.1080/03007995.2020.1808452. Epub 2020 Sep 29.
4
5
Cytomegalovirus and Epstein-Barr virus-associated post-transplant lymphoproliferative disorder after allogeneic hematopoietic stem cell transplantation.异基因造血干细胞移植后巨细胞病毒和爱泼斯坦-巴尔病毒相关的移植后淋巴增殖性疾病
Ann Hematol. 2011 Jan;90(1):113-4. doi: 10.1007/s00277-010-0947-8. Epub 2010 Apr 6.
6
EBV lymphoproliferative disease of host origin after haploidentical stem cell transplantation.单倍体相合造血干细胞移植后宿主来源的EB病毒淋巴增殖性疾病
Pediatr Blood Cancer. 2007 Nov;49(6):869-72. doi: 10.1002/pbc.20710.
7
T-cell lymphoproliferative disorder following a full haplotype-mismatched haematopoietic stem cell transplant in a patient with acute myeloid leukaemia.一名急性髓系白血病患者在接受完全单倍型不匹配的造血干细胞移植后发生的T细胞淋巴增殖性疾病。
Bone Marrow Transplant. 2005 Sep;36(5):461-3. doi: 10.1038/sj.bmt.1705068.
8
Posttransplant lymphoproliferative disorder complicating hematopoietic stem cell transplantation in a patient with dyskeratosis congenita.先天性角化不良患者造血干细胞移植后并发移植后淋巴细胞增殖性疾病
Int J Surg Pathol. 2013 Oct;21(5):520-5. doi: 10.1177/1066896912468214. Epub 2012 Dec 5.
9
Wilms' tumor gene 1 is an independent prognostic factor for pediatric acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation.Wilms' 肿瘤基因 1 是异基因造血干细胞移植后儿童急性髓系白血病的独立预后因素。
BMC Cancer. 2021 Mar 19;21(1):292. doi: 10.1186/s12885-021-08022-0.
10
Interferon-α Is Effective for Treatment of Minimal Residual Disease in Patients with t(8;21) Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation: Results of a Prospective Registry Study.干扰素-α 对异基因造血干细胞移植后 t(8;21) 急性髓系白血病患者微小残留病的治疗有效：一项前瞻性登记研究的结果。
Oncologist. 2018 Nov;23(11):1349-1357. doi: 10.1634/theoncologist.2017-0692. Epub 2018 Aug 3.
本文引用的文献
1
Reexamining post-transplant lymphoproliferative disorders: Newly recognized and enigmatic types.重新审视移植后淋巴细胞增生性疾病：新发现的及神秘的类型。
Semin Diagn Pathol. 2018 Jul;35(4):236-246. doi: 10.1053/j.semdp.2018.02.001. Epub 2018 Mar 3.
2
Successful management of concurrent acquired hemophilia A and a lupus anticoagulant in a pediatric hematopoietic stem cell transplant patient.一名儿科造血干细胞移植患者同时获得性血友病A和狼疮抗凝物的成功管理。
Bone Marrow Transplant. 2018 Apr;53(4):487-489. doi: 10.1038/s41409-017-0041-0. Epub 2018 Jan 12.
3
Post-transplant lymphoproliferative disorder (PTLD): single institutional experience of 141 patients.移植后淋巴细胞增生性疾病（PTLD）：141例患者的单机构经验
Exp Hematol Oncol. 2017 Sep 29;6:26. doi: 10.1186/s40164-017-0087-0. eCollection 2017.
4
Acquired haemophilia in cancer: A systematic and critical literature review.癌症相关性获得性血友病：系统且批判性文献回顾。
Haemophilia. 2018 Jan;24(1):43-56. doi: 10.1111/hae.13355. Epub 2017 Sep 27.
5
Long-term outcome of Epstein-Barr virus DNAemia and PTLD with the use of preemptive rituximab following allogeneic HSCT.异基因造血干细胞移植后使用抢先性利妥昔单抗治疗爱泼斯坦-巴尔病毒血症和移植后淋巴增殖性疾病的长期结果
Leuk Lymphoma. 2018 May;59(5):1172-1179. doi: 10.1080/10428194.2017.1365860. Epub 2017 Aug 23.
6
EBV-negative monomorphic B-cell post-transplant lymphoproliferative disorders are pathologically distinct from EBV-positive cases and frequently contain TP53 mutations.EBV 阴性单形性 B 细胞移植后淋巴组织增生性疾病在病理学上与 EBV 阳性病例不同，并且经常包含 TP53 突变。
Mod Pathol. 2016 Oct;29(10):1200-11. doi: 10.1038/modpathol.2016.130. Epub 2016 Jul 22.
7
Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelines.异基因造血干细胞移植后患者的爱泼斯坦-巴尔病毒感染及移植后淋巴增殖性疾病的管理：第六届欧洲白血病感染会议（ECIL-6）指南
Haematologica. 2016 Jul;101(7):803-11. doi: 10.3324/haematol.2016.144428.
8
The anti-CD20 monoclonal antibody rituximab to treat acquired haemophilia A.抗CD20单克隆抗体利妥昔单抗治疗获得性血友病A。
Blood Transfus. 2016 May;14(2):255-61. doi: 10.2450/2015.0090-15. Epub 2015 Sep 3.
9
Efficacy and safety of OBI-1, an antihaemophilic factor VIII (recombinant), porcine sequence, in subjects with acquired haemophilia A.重组猪序列抗血友病因子VIII（OBI-1）在获得性血友病A患者中的疗效和安全性。
Haemophilia. 2015 Mar;21(2):162-170. doi: 10.1111/hae.12627. Epub 2015 Jan 27.
10
Prognostic factors for remission of and survival in acquired hemophilia A (AHA): results from the GTH-AH 01/2010 study.获得性血友病A（AHA）缓解及生存的预后因素：GTH-AH 01/2010研究结果
Blood. 2015 Feb 12;125(7):1091-7. doi: 10.1182/blood-2014-07-587089. Epub 2014 Dec 18.
Zotero 插件